Research collaboration to characterize extracellular vesicles (EVs) produced by the fungal pathogen Botrytis cinerea, aiming to identify virulence factors carried in EV cargo that can serve as novel fungicide targets. The 12-month study combines EV isolation, proteomic and metabolomic analysis, and plant-based bioassays to deliver a pool of candidate compounds for crop protection.
This research program targets extracellular vesicles (EVs) produced by Botrytis cinerea, one of the world's most destructive crop pathogens. The project investigates whether EVs released by this fungus concentrate virulence factors such as effector proteins, RNAs, lipids, metabolites, and polysaccharides that facilitate plant infection. By systematically profiling EV cargo, the team aims to uncover previously unrecognized molecular targets that can be exploited for next-generation fungicide development. The work addresses a critical gap: while EVs have been documented in more than 20 fungal species, their presence and composition in B. cinerea remain uncharacterized. Outcomes include a curated pool of candidate virulence-associated compounds and a validated methodological pipeline for studying fungal EVs as a source of crop-protection targets.
Research approach and capabilities:
Team expertise:
This is an early-stage discovery research program at Technology Readiness Level 2–3 (concept validation through laboratory demonstration). The methodology draws on validated EV isolation and characterization techniques already applied to other fungal pathogens, reducing technical risk. The 12-month plan progresses from establishing B. cinerea EV isolation conditions, through cargo profiling, to functional testing on strawberry plants. The team is actively seeking collaboration and funding support for equipment, consumables, instrument access, analytical costs, and mentorship on producing translatable research outcomes.
La Trobe University is a comprehensive public research university based in Melbourne, serving metropolitan and regional Australia through a multi‑campus footprint. Its Research and Innovation Precinct at the Bundoora campus enables industry co‑location, shared facilities, and streamlined access to talent. Collaborations with state agencies and Melbourne’s hospital network, plus a digital innovation hub and accelerator programs, provide pathways for prototyping, validation, and co‑development. Research is supported by competitive national funding, including the Australian Research Council and National Health and Medical Research Council, alongside industry partnerships and Cooperative Research Centre programs. A dedicated technology transfer office manages IP, licensing, and startup formation.